Haojun Xu

S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways

Dan Fang, Chengfei Zhang, Ping Xu et al. · Cell Biology and Toxicology · 2021 · 53 citations

Medicine, Cancer Biology, Oncology +14

The androgen receptor expression and association with patient's survival in different cancers

Dan Fang, Haojun Xu, Qianghu Wang et al. · Genomics · 2019 · 51 citations

Medicine, Endocrinology, Oncology +14

STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway

Chengfei Zhang, Xiaoming Wang, Dan Fang et al. · Theranostics · 2020 · 44 citations · Full text

Medicine, Cell Biology, Oncology +17

Understanding the inflammation-cancer transformation in the development of primary liver cancer

Hongjin Chen, Minghua Hu, Fanggui Xu et al. · Hepatoma Research · 2018 · 40 citations · Full text

Medicine, Oncology, Pathology +17

KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma

Mo Xiao, Ping Xu, Min Ding et al. · Acta Pharmacologica Sinica · 2021 · 40 citations · Full text

Life Sciences, Cell Biology, Oncology +8